Outlook on the Medical Enzyme Technology Global Market to 2028 - Rising Production of Biopharmaceutical Products Presents Opportunities - ResearchAndMarkets.com

Abnormalities in enzyme metabolism system leads to many metabolic diseases.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, May 14, 2021
Information
Tags: 
Biotechnology, Pharmaceutical, Health, Branches of biology, Medical specialties, Biology, Medical genetics, Metabolism, Pancreas disorders, Abdominal pain, Pancreatitis, Jaundice, Metabolic disorder, Aspartate transaminase, Neurodegeneration
Geotags: 
US
Summary
Key Points: 
  • Abnormalities in enzyme metabolism system leads to many metabolic diseases.
  • Many enzymes are being widely used in the clinical examination as a specific disease marker.
  • Enzymes are the preferred markers in various disease states such as myocardial infarction, jaundice, pancreatitis, cancer, and neurodegenerative disorders.
  • However, the market for normothermic machine perfusion is estimated to grow at a higher CAGR of 4.4% during the forecast period.\nThe medical enzyme technology market, by application, is segmented into disease treatment, diagnostic tools, biomedical research, and others.


The "Medical Enzyme Technology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Enzyme Type; Application, and Geography" report has been added to ResearchAndMarkets.com's offering.

The global medical enzyme technology market is expected to reach US$ 6,700.00 million by 2028 from US$ 4,012.57 million in 2020; it is estimated to grow at a CAGR of 6.7% during 2021-2028.

Enzymes play a crucial role in the metabolic activities of all organisms. They have an extensive range of applications in microbial biotechnology and diagnosis processes. Abnormalities in enzyme metabolism system leads to many metabolic diseases. Many enzymes are being widely used in the clinical examination as a specific disease marker. Further, medicinal enzymes can be used as medicines to treat a range of diseases. They are characterized by remarkable curative effect and insignificant side effects. For example, trypsin can be used to accelerate wound healing, dissolve blood clots, remove necrotic tissue, and inhibit contaminant growth (in cell cultures). L-asparaginase can be used to treat cancer by depriving nutrients needed for the growth of cancer cells. Protease (provide in the form of multi-enzyme tablets) can be used to treat dyspepsia; many proteases have anti-inflammatory properties.

Moreover, lipase, superoxide dismutase, nattokinase, soybean meal plasmin, and thrombin, among others, can be used to treat various diseases. Enzymes are the preferred markers in various disease states such as myocardial infarction, jaundice, pancreatitis, cancer, and neurodegenerative disorders. They assist in diagnosis, prognosis, and assessment of response therapy. Furthermore, many enzymes are used as diagnostic reagents. Due to the unique enzyme characteristics of specificity, high-catalytic efficiency, and mild action conditions, the enzymatic diagnosis has become a reliable, simple, and rapid method.

The medical enzyme technology market, by enzyme type, is segmented into digestive enzymes, thrombolytic enzymes, hydrolases, and endonucleases. The hydrolases segment held the largest share of the market in 2020; however, the thrombolytic enzymes segment is anticipated to register the highest CAGR of 7.2% during the forecast period.

In terms of technique, the medical enzyme technology market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held a larger market share in 2019. However, the market for normothermic machine perfusion is estimated to grow at a higher CAGR of 4.4% during the forecast period.

The medical enzyme technology market, by application, is segmented into disease treatment, diagnostic tools, biomedical research, and others. The disease treatment segment held the largest share of the market in 2020, and the same segment is anticipated to register the highest CAGR of 7.1% in the market during the forecast period.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the medical enzyme technology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global medical enzyme technology market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Market Dynamics

Drivers

  • Applications of Enzymes in Diagnosis and Disease Treatment
  • Significant Increase in Research and Development Activities

Restraints

  • Handling and Safety Issues Related to Enzymes

Opportunities

  • Rising Production of Biopharmaceutical Products

Future Trends

  • Advancements in Enzyme Engineering

Companies Mentioned

  • Merck
  • Thermo Fisher Scientific Inc.
  • Novozymes
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • Agilent Technologies, Inc.
  • Danaher (Cytiva)
  • Sanofi
  • Asahi Kasei Corporation
  • Promega Corporation
  • Amano Enzyme Inc
  • Genzyme Corporation

For more information about this report visit https://www.researchandmarkets.com/r/ixgs1w

Copyright: 
Copyright Business Wire 2021